You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(11.3)︱中國恆大前10個月銷售6325億元,已超過去年全年
格隆匯 11-03 22:58

【分拆上市】

中國恆大:擬分拆物業上市,合資格股東享優先認股權

業績預告】

量子思維(08050.HK)預計中期業績扭虧為盈

創建集團控股(01609.HK)預期中期淨虧約5000萬港元-6000萬港元

鄺文記(08023.HK)預計中期盈利大幅增加約1300萬港元

瀛海集團(08668.HK)預期第三季度淨虧約1650萬港元-1850萬港元

智城發展控股(08268.HK)預期中期純利不多於400萬港元

圓美光電(08311.HK)預計首九月虧損減少約30%

NOMAD TECH(08645.HK)預計首季錄得税後虧損淨額約7000令吉

【營運數據】

中國恆大(03333.HK):前10個月累計銷售6325.9億元 完成年度目標的97.3%

萬科企業(02202.HK)10月銷售額達523.1億元

融信中國(03301.HK)前10個月銷售額達1148.32億元

當代置業(01107.HK)10月銷售額50.37億元 同比增長61%

美的置業(03990.HK):前十月合同銷售974.5億元 同比增長19.42%

大發地產(06111.HK)前十月實現累計合同銷售額231.05億元

大酒店(00045.HK):第三季度半島酒店香港出租率為26%

捷利交易寶(08017.HK)10月註冊用户數量43.6萬户 同比增長71.2%

【併購出售】

合生創展集團(00754.HK)擬1.82億美元認購元知開曼20%股權 元知BVI認購合生活20%股權家鄉互動(03798.HK)擬1.5億元收購心悦網絡科技40%股權

朗生醫藥(00503.HK)擬減持不超1.87%司太立股份

中國鋁業(02600.HK):山東華宇13.5萬噸電解鋁產能指標拍賣成功 拍賣價5.39億元

和泓服務(06093.HK)擬1200萬元收購內蒙古一物管公司65%股權

和泓服務(06093.HK)擬1540萬元收購中正物業管理51%股權

【增發供股】

嘗高美集團(08371.HK)擬先舊後新配股 籌資約957.6萬港元

【投資與運營】

雲頂新耀-B(01952.HK):三陰性乳腺癌治療藥物2b期註冊臨牀試驗首例患者給藥完成

遠大醫藥(00512.HK):美國FDA批准COVID-19疫苗項目CORVax12進行I期臨牀試驗

浙江滬杭甬(00576.HK):浙商證券定增申請獲證監會審核通過

石藥集團(01093.HK):創新藥“SYHA1813口服液”獲臨牀試驗批件

復星醫藥(02196.HK):丙硫氧嘧啶片通過仿製藥質量與療效一致性評價

藥明康德(02359.HK)參股公司JW (Cayman) Therapeutics Co.,Ltd.在港交所掛牌上市

新意網集團(01686.HK)訂立建築合同興建高端數據中 合同總額36.05億港元

捷心隆(02115.HK)就收購新工廠獲推介數個具潛力收購目標

【基金理財】

泰升集團(00687.HK)擬退出參與基金

【公司改名】

雅生活服務(03319.HK)擬更名為”雅生活智慧城市服務股份有限公司“

中信大錳(01091.HK)擬更名為"南方錳業投資有限公司"

【回購註銷】

恆安國際(01044.HK)11月3日耗資2678.16萬港元回購50萬股

復星國際(00656.HK)11月3日耗資1367.69萬港元回購141.5萬股

建滔集團(00148.HK)11月3日耗資791.88萬港元回購30萬股

石四藥集團(02005.HK)11月3日耗資145.1萬港元回購33.8萬股

東瑞製藥(02348.HK)11月3日耗資157.10萬港元回購179.2萬股

【股權激勵】

信陽毛尖(00362.HK)授出1.295億份購股權

連成科技集團(08635.HK)授出合共160萬份購股權

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account